Scinovex
article Open AccessTop 1% cited

Ocular manifestations of a hospitalised patient with confirmed 2019 novel coronavirus disease

British Journal of Ophthalmology · 2020 · Vol. 104(6) · pp. 748–751
Lu ChenMeizhou LiuZheng ZhangKun QiaoTing HuangMiaohong ChenNa XinZu-Liang HuangLei LiuGuoming ZhangJiantao Wang

Abstract

SARS-CoV-2 is capable of causing ocular complications such as viral conjunctivitis in the middle phase of illness. Precautionary measures are recommended when examining infected patients throughout the clinical course of the infection. However, conjunctival sampling might not be useful for early diagnosis because the virus may not appear initially in the conjunctiva.

Retinal and Optic ConditionsOcular Diseases and Behçet’s SyndromeCerebral Venous Sinus ThrombosisMedicineCoronavirus disease 2019 (COVID-19)Disease2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)CoronavirusPandemicEye diseasePediatricsOphthalmology

MeSH terms

BetacoronavirusCOVID-19SARS-CoV-2AdultAntiviral AgentsConjunctivitis, ViralHumansMaleNasal CavityOphthalmic SolutionsPharynxPneumonia, ViralRibavirinRNA, ViralTreatment Outcome

Funding

  • National Natural Science Foundation of China
Citations
381
FWCI
58.09
field-weighted impact
References
20
Percentile
100%
vs. same field & year
Citations per year
Cited by
De-mystifying asymptomatic carriers of SARS-CoV-2 and saliva as a new plethora for diagnosis
International Journal of Applied Dental Sciences · 2020 · 0 citations
Study of the value of serum amyloid a for predicting the severity and recovery of COVID 19
International Journal of Clinical and Diagnostic Pathology · 2024 · 0 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.